Dyslipidemias (Dyslipidemia) Summary

Networked: 8536 relevant articles (538 outcomes, 1027 trials/studies) for this Disease

Key Drugs and Agents for Dyslipidemias

1. Insulin (Novolin) : 46 outcomes 40 studies in 616 results : FDA 2
   
2. atorvastatin (Lipitor) : 43 outcomes 63 studies in 193 results : FDA 2
   
3. Glucose (Dextrose) : 38 outcomes 94 studies in 1025 results : FDA 175 Generic
   
4. Cholesterol : 37 outcomes 83 studies in 776 results : IBA
   
5. Niacin (Nicotinic Acid) : 37 outcomes 35 studies in 237 results : FDA 21 Generic
   
6. Lipoproteins (Lipoprotein) : 33 outcomes 79 studies in 838 results : IBA
   
7. HDL Cholesterol : 27 outcomes 60 studies in 804 results : IBA
   
8. Simvastatin (Zocor) : 21 outcomes 41 studies in 120 results : FDA 20 Generic
   
9. Triglycerides (Triacylglycerol) : 21 outcomes 34 studies in 594 results : IBA
   
10. Fenofibrate (CiL) : 20 outcomes 39 studies in 162 results : FDA 14 Generic
    

Diseases Related to Dyslipidemias

1. Hypertension (High Blood Pressure)
2. Insulin Resistance
3. Obesity
4. Hyperglycemia
5. Cardiovascular Diseases (Cardiovascular Disease)

Key Therapies for Dyslipidemias

1. Bariatric Surgery : 11 outcomes 4 studies in 37 results
   
2. Transplants (Transplant) : 10 outcomes 10 studies in 110 results
   
3. Transplantation (Transplant Recipients) : 9 outcomes 10 studies in 107 results
   
4. Drug Therapy (Chemotherapy) : 7 outcomes 12 studies in 147 results
   
5. Highly Active Antiretroviral Therapy (HAART) : 5 outcomes 12 studies in 121 results